FLDM
Income statement / Annual
Last year (2024), Standard BioTools Inc.'s total revenue was $174.43 M,
an increase of 33.58% from the previous year.
In 2024, Standard BioTools Inc.'s net income was -$184.90 M.
See Standard BioTools Inc.,s key income statements, including revenue, expenses, profit, and income.
| Period |
FY-2024
|
FY-2021
|
FY-2020
|
FY-2019
|
FY-2018
|
FY-2017
|
FY-2016
|
FY-2015
|
FY-2014
|
FY-2013
|
| Period Ended |
12/31/2024 |
12/31/2021 |
12/31/2020 |
12/31/2019 |
12/31/2018 |
12/31/2017 |
12/31/2016 |
12/31/2015 |
12/31/2014 |
12/31/2013 |
| Operating Revenue |
$174.43 M |
$130.58 M |
$138.14 M |
$117.24 M |
$112.96 M |
$101.94 M |
$104.45 M |
$114.71 M |
$116.46 M |
$71.18 M |
| Cost of Revenue |
$90.17 M
|
$61.21 M
|
$54.82 M
|
$52.96 M
|
$51.32 M
|
$49.96 M
|
$46.01 M
|
$46.63 M
|
$42.85 M
|
$20.20 M
|
| Gross Profit |
$84.26 M
|
$69.37 M
|
$83.33 M
|
$64.28 M
|
$61.65 M
|
$51.98 M
|
$58.44 M
|
$68.08 M
|
$73.61 M
|
$50.98 M
|
| Gross Profit Ratio |
0.48
|
0.53
|
0.6
|
0.55
|
0.55
|
0.51
|
0.56
|
0.59
|
0.63
|
0.72
|
| Research and Development Expenses |
$62.41 M
|
$37.94 M
|
$36.46 M
|
$31.64 M
|
$30.03 M
|
$30.83 M
|
$38.42 M
|
$39.26 M
|
$43.42 M
|
$19.95 M
|
| General & Administrative Expenses |
$0.00
|
$0.00
|
$97.90 M
|
$84.48 M
|
$79.78 M
|
$79.52 M
|
$93.21 M
|
$82.96 M
|
$71.32 M
|
$48.41 M
|
| Selling & Marketing Expenses |
$0.00
|
$0.00
|
$0.00
|
$0.00
|
$0.00
|
$0.00
|
$0.00
|
$0.00
|
$0.00
|
$0.00
|
| Selling, General & Administrative Expenses |
$156.61 M
|
$98.89 M
|
$97.90 M
|
$84.48 M
|
$79.78 M
|
$79.52 M
|
$93.21 M
|
$82.96 M
|
$71.32 M
|
$48.41 M
|
| Other Expenses |
$0.00
|
$0.00
|
$0.00
|
$0.00
|
$0.00
|
$0.00
|
$0.00
|
$0.00
|
$0.00
|
$0.00
|
| Operating Expenses |
$219.02 M
|
$136.83 M
|
$134.36 M
|
$116.12 M
|
$109.81 M
|
$110.34 M
|
$131.63 M
|
$122.22 M
|
$114.75 M
|
$68.37 M
|
| Cost And Expenses |
$309.19 M
|
$198.04 M
|
$189.18 M
|
$169.08 M
|
$161.13 M
|
$160.30 M
|
$177.64 M
|
$168.85 M
|
$157.60 M
|
$88.57 M
|
| Interest Income |
$20.20 M
|
$0.00
|
$0.00
|
$0.00
|
$0.00
|
$0.00
|
$0.00
|
$0.00
|
$0.00
|
$0.00
|
| Interest Expense |
-$3.32 M
|
$3.82 M
|
$3.57 M
|
$4.28 M
|
$13.89 M
|
$5.82 M
|
$5.82 M
|
$5.81 M
|
$5.34 M
|
$14.00 K
|
| Depreciation & Amortization |
$0.00
|
$15.57 M
|
$15.92 M
|
$15.81 M
|
$16.57 M
|
$18.61 M
|
$17.94 M
|
$16.12 M
|
$13.86 M
|
$2.55 M
|
| EBITDA |
-$175.24 M |
-$44.27 M |
-$34.61 M |
-$46.62 M |
-$30.96 M |
-$39.37 M |
-$56.42 M |
-$32.87 M |
-$38.50 M |
-$13.82 M |
| EBITDA Ratio |
-1
|
-0.34
|
-0.25
|
-0.4
|
-0.27
|
-0.39
|
-0.54
|
-0.29
|
-0.33
|
-0.19
|
| Operating Income Ratio |
-1
|
-0.46
|
-0.37
|
-0.44
|
-0.43
|
-0.57
|
-0.7
|
-0.44
|
-0.45
|
-0.26
|
| Total Other Income/Expenses Net |
$36.92 M
|
-$3.82 M
|
-$3.07 M
|
-$14.87 M
|
-$13.26 M
|
-$5.44 M
|
-$6.99 M
|
-$4.64 M
|
-$5.87 M
|
$2.26 M
|
| Income Before Tax |
-$138.31 M
|
-$63.66 M
|
-$54.10 M
|
-$66.71 M
|
-$61.42 M
|
-$63.80 M
|
-$80.18 M
|
-$54.79 M
|
-$57.71 M
|
-$16.39 M
|
| Income Before Tax Ratio |
-0.79
|
-0.49
|
-0.39
|
-0.57
|
-0.54
|
-0.63
|
-0.77
|
-0.48
|
-0.5
|
-0.23
|
| Income Tax Expense |
-$573.00 K
|
-$4.42 M
|
-$1.08 M
|
-$1.92 M
|
-$2.41 M
|
-$3.26 M
|
-$4.19 M
|
-$1.48 M
|
-$4.88 M
|
$137.00 K
|
| Net Income |
-$184.90 M
|
-$59.24 M
|
-$53.02 M
|
-$64.79 M
|
-$59.01 M
|
-$60.54 M
|
-$75.99 M
|
-$53.32 M
|
-$52.83 M
|
-$16.53 M
|
| Net Income Ratio |
-1.06
|
-0.45
|
-0.38
|
-0.55
|
-0.52
|
-0.59
|
-0.73
|
-0.46
|
-0.45
|
-0.23
|
| EPS |
-0.52 |
-0.78 |
-0.74 |
-0.97 |
-1.49 |
-1.84 |
-2.62 |
-1.86 |
-1.9 |
-0.65 |
| EPS Diluted |
-0.52 |
-0.78 |
-0.74 |
-0.97 |
-1.49 |
-1.84 |
-2.62 |
-1.86 |
-1.9 |
-0.65 |
| Weighted Average Shares Out |
$353.25 M
|
$76.30 M
|
$72.04 M
|
$66.78 M
|
$39.65 M
|
$32.98 M
|
$29.01 M
|
$28.71 M
|
$27.77 M
|
$25.48 M
|
| Weighted Average Shares Out Diluted |
$353.25 M
|
$76.30 M
|
$72.04 M
|
$66.78 M
|
$39.65 M
|
$32.98 M
|
$29.01 M
|
$28.71 M
|
$27.77 M
|
$25.48 M
|
| Link |
|
|
|
|
|
|
|
|
|
|
